VVUS

VIVUS, Inc. News Headlines

$3.32
*  
0.15
4.73%
Get VVUS Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading VVUS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Arena And Vivus Investors Need To Grasp Implications Of Orexigen
12/19/2014 2:22:00 PM - Seeking Alpha


Vivus Tries To Lead Obesity Space With Insurance Coverage
12/16/2014 6:23:00 AM - Seeking Alpha


Low-Cost Contrave Fuels Anti-Obesity Drugs Recovery From Thanksgiving
12/16/2014 1:50:00 AM - Seeking Alpha


Why Should Investors Expect Physicians To Treat Obesity With Pharmacotherapy?
12/15/2014 10:30:00 AM - Seeking Alpha


Contrave Sales Continue To Impress
12/12/2014 4:26:00 PM - Seeking Alpha


This Growing Concern Accounts For Nearly 500,000 Cancer Cases Each Year
12/7/2014 1:51:02 PM - Motley Fool


Will Diabetes Drugs Enter The Anti-Obesity Space?
12/7/2014 6:58:00 AM - Seeking Alpha


Could This Company Follow in Dendreon's Footsteps?
12/3/2014 11:11:03 AM - Motley Fool


Why Orexigen Therapeutics, Inc. Stock Rocketed 43% Higher in November
12/3/2014 8:36:03 AM - Motley Fool


Belviq Approaches 10,000 Ads Aired
12/1/2014 2:42:00 PM - Seeking Alpha


Vivus Gets Two Additional U.S. Patents For Qsymia - Quick Facts
11/26/2014 7:17:00 AM - RTT News


Arena Pharmaceuticals: Belviq Sales Take A Modest Dip With Holiday
11/22/2014 2:51:00 PM - Seeking Alpha


Why VIVUS (VVUS) Might Be a Diamond in the Rough - Tale of the Tape
11/19/2014 9:07:00 AM - Zacks.com


Janssen Is Working Its Way Toward Anti-Obesity
11/17/2014 5:14:00 PM - Seeking Alpha


EnteroMedics May Enter The Obesity Space - What Does It Mean?
11/17/2014 4:43:00 PM - Seeking Alpha


For This Obesity Drug, Europe Trumps the U.S.
11/17/2014 4:00:15 PM - Motley Fool


ARNA Management And Investors Underestimating The Potential Of Belviq And Phentermine Combination
11/13/2014 9:52:00 AM - Seeking Alpha


Bel-Phen Pilot Study News, Hold On To Your Shares
11/11/2014 1:13:00 PM - Seeking Alpha


Orexigen Turns Around with Q3 Earnings Beat, Shares Soar - Analyst Blog
11/11/2014 11:20:00 AM - Zacks.com


Can Arena Pharmaceuticals Inc. Overcome Belviq's Slow Launch?
11/11/2014 11:15:02 AM - Motley Fool


Why Orexigen Therapeutics, Inc. Stock Skyrocketed
11/10/2014 6:52:20 PM - Motley Fool


Arena And Vivus Investors Need To Watch Orexigen
11/10/2014 1:24:00 PM - Seeking Alpha


3 Crashing Stocks: Is 1 a Buy?
11/9/2014 11:45:02 AM - Motley Fool


Belviq Sales Dip Slightly - Quarter Is Flat Thus Far
11/7/2014 1:02:00 PM - Seeking Alpha


VIVUS Posts Narrower-than-Expected Q3 Loss, Revenues Up - Analyst Blog
11/6/2014 4:45:00 PM - Zacks.com